Gordon joined Cavendish Corporate Finance in 2009 to lead coverage of the healthcare sector. Gordon has sixteen years’ experience of advising healthcare companies, both public and private, on a range of transactions and financial products. Since working with Cavendish, Gordon has completed many deals such as the sale of Barbican Dental Care to Bupa, the sale of leading thermo logistics firm Polar Speed to UPS and the sale of Kent Pharmaceuticals to DCC Plc.
Gordon led the life science team at Deloitte Corporate Finance and Healthcare team at ING prior to joining Cavendish. Gordon also spent five years in Citigroup's healthcare team working in both New York and London, before which he qualified as an ACA with Arthur Andersen, where he worked in the Healthcare Corporate Finance team in both London and New York.
Gordon studied Pharmacology at the University of Aberdeen followed by a PhD in Pharmacology at Cambridge University.
The Cavendish Chemicals Group focuses on the sale of businesses in the chemical and related sectors, both manufacturers & distributors.
The Cavendish Healthcare Group focuses on the sale of businesses in the healthcare sector.
Linda , Gordon and the team at Cavendish were superb. They managed a competitive sale process and generated interest from international buyers from the broad media and healthcare sectors.
Dr Wayne Phillips, CEO of Double Helix
Cavendish Corporate Finance, the UK’s leading sell-side mid-market M&A firm, has advised on the sale of The Planning Shop international, a specialist healthcare brand strategy agency, to...
Cavendish Corporate Finance is delighted to announce the sale of leading thermo logistics firm Polar Speed to the world’s largest logistics company UPS. Founded in 1996, Polar Speed specialises in...